| Development of a blood-brain barrier model in a membrane-based microchip for characterization of drug permeability and cytotoxicity for drug screening X Shao, D Gao, Y Chen, F Jin, G Hu, Y Jiang, H Liu Analytica chimica acta 934, 186-193, 2016 | 61 | 2016 |
| Synthesis and investigation of novel 6-(1, 2, 3-triazol-4-yl)-4-aminoquinazolin derivatives possessing hydroxamic acid moiety for cancer therapy C Ding, S Chen, C Zhang, G Hu, W Zhang, L Li, YZ Chen, C Tan, Y Jiang Bioorganic & medicinal chemistry 25 (1), 27-37, 2017 | 57 | 2017 |
| A novel DNA and protein combination COVID-19 vaccine formulation provides full protection against SARS-CoV-2 in rhesus macaques Y Li, Y Bi, H Xiao, Y Yao, X Liu, Z Hu, J Duan, Y Yang, Z Li, Y Li, H Zhang, ... Emerging microbes & infections 10 (1), 342-355, 2021 | 42 | 2021 |
| Development of N, S-doped carbon dots as a novel matrix for the analysis of small molecules by negative ion MALDI-TOF MS Y Wang, D Gao, Y Chen, G Hu, H Liu, Y Jiang RSC advances 6 (82), 79043-79049, 2016 | 31 | 2016 |
| A novel hypoxia-induced miR-147a regulates cell proliferation through a positive feedback loop of stabilizing HIF-1α F Wang, H Zhang, N Xu, N Huang, C Tian, A Ye, G Hu, J He, Y Zhang Cancer biology & therapy 17 (8), 790-798, 2016 | 29 | 2016 |
| Serine/arginine-rich splicing factor 2 modulates herpes simplex virus type 1 replication via regulating viral gene transcriptional activity and pre-mRNA splicing Z Wang, Q Liu, J Lu, P Fan, W Xie, W Qiu, F Wang, G Hu, Y Zhang Journal of Biological Chemistry 291 (51), 26377-26387, 2016 | 21 | 2016 |
| Structural analysis of a novel rabbit monoclonal antibody R53 targeting an epitope in HIV-1 gp120 C4 region critical for receptor and co-receptor binding R Pan, Y Chen, M Vaine, G Hu, S Wang, S Lu, XP Kong Emerging Microbes & Infections 4 (1), 1-8, 2015 | 17 | 2015 |
| Glycan profiles of gp120 protein vaccines from four major HIV-1 subtypes produced from different host cell lines under non-GMP or GMP conditions S Wang, Y Voronin, P Zhao, M Ishihara, N Mehta, M Porterfield, Y Chen, ... Journal of Virology 94 (7), 10.1128/jvi. 01968-19, 2020 | 15 | 2020 |
| Non-neutralizing antibodies targeting the immunogenic regions of HIV-1 envelope reduce mucosal infection and virus burden in humanized mice CE Hioe, G Li, X Liu, O Tsahouridis, X He, M Funaki, J Klingler, AF Tang, ... PLoS pathogens 18 (1), e1010183, 2022 | 11 | 2022 |
| Screening of primary gp120 immunogens to formulate the next generation polyvalent DNA prime-protein boost HIV-1 vaccines S Wang, T Chou, A Hackett, V Efros, Y Wang, D Han, A Wallace, Y Chen, ... Human Vaccines & Immunotherapeutics 13 (12), 2996-3009, 2017 | 10 | 2017 |
| Influence of wine-processing on the pharmacokinetics of anthraquinone aglycones and glycosides from rhubarb in hyperlipidemic hamsters M Wang, G Hu, Y Tian, Z Zhang, R Song RSC advances 6 (30), 24871-24879, 2016 | 8 | 2016 |
| Broadly binding and functional antibodies and persisting memory B cells elicited by HIV vaccine PDPHV S Wang, NL Yates, J Pollara, Y Voronin, S Stanfield-Oakley, D Han, G Hu, ... NPJ vaccines 7 (1), 18, 2022 | 7 | 2022 |
| DNA priming immunization is more effective than recombinant protein vaccine in eliciting antigen-specific B cell responses H Li, S Wang, G Hu, L Zhang, S Liu, S Lu Emerging Microbes & Infections 10 (1), 833-841, 2021 | 6 | 2021 |
| Human CD4-Binding Site Antibody Elicited by Polyvalent DNA Prime-Protein Boost Vaccine Neutralizes Cross-Clade Tier-2-HIV Strains S Wang, KW Chan, D Wei, X Ma, S Liu, G Hu, S Park, R Pan, Y Gu, ... Research Square, 2023 | | 2023 |
